Cybrdi, Inc. Asset Turnover Ratio (CYDI), as of third quarter 2014, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Cybrdi, Inc.  (CYDI)
 

Cybrdi Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Cybrdi's asset turnover ratio has remained unchanged compare to previous quarter at 0.05 in the third quarter (Sep 30 2014)

Within sector 20 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2014 compared to the preceding quarter from 1434 to 3514.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CYDI Asset Turnover Ratio (Sep 30 2014)
III. Quarter		 (Jun 30 2014)
II. Quarter		 (Mar 31 2014)
I. Quarter		 (Dec 31 2013)
IV. Quarter		 (Sep 30 2013)
III. Quarter
Y / Y Asset Change -1.8 % -1.42 % -5.35 % -1.88 % 4.34 %
Y / Y Revenue Change -15.81 % -38.35 % -1.57 % -49.4 % 3.03 %
Asset Turnover Ratio (TTM) 0.05 0.05 0.05 0.05 0.07
CYDI's Total Ranking # 3514 # 1434 # 1434 # 0 # 1434
Seq. Asset Change 1.02 % 4.24 % -2.4 % -4.46 % 1.41 %
Seq. Revenue Change 30.88 % -42.52 % -1.79 % 13.96 % -4.17 %



Asset Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 21
Healthcare Sector # 326
Overall Market # 3514

Asset Turnover Ratio Statistics
High Average Low
0.08 0.06 0.05
(Dec 31 2012)  




CYDI Company Profile • Back to CYDI Efficiency Comparisons • Compare CYDI Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2014, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2014 Assets at quarter ending Sep 30 2014
Immunomedics Inc   0.13 $ 4.617  Millions$ 35.924  Millions
Curis Inc   0.13 $ 9.375  Millions$ 74.516  Millions
Viracta Therapeutics Inc   0.13 $ 6.827  Millions$ 54.530  Millions
Karyopharm Therapeutics Inc   0.12 $ 21.213  Millions$ 170.086  Millions
Arqule Inc  0.12 $ 10.514  Millions$ 84.512  Millions
Novavax inc   0.12 $ 32.683  Millions$ 264.760  Millions
Ironwood Pharmaceuticals inc   0.12 $ 43.394  Millions$ 353.766  Millions
Geovax Labs Inc   0.12 $ 0.232  Millions$ 1.897  Millions
Guided Therapeutics Inc   0.12 $ 0.397  Millions$ 3.364  Millions
Acceleron Pharma inc  0.12 $ 22.414  Millions$ 190.532  Millions
Acadia Pharmaceuticals Inc   0.12 $ 37.073  Millions$ 315.963  Millions
Aac Holdings, Inc.  0.11 $ 36.599  Millions$ 341.644  Millions
Arena Pharmaceuticals Inc   0.10 $ 34.295  Millions$ 334.712  Millions
Aspira Women s Health inc   0.10 $ 2.548  Millions$ 24.958  Millions
Bluebird Bio Inc   0.10 $ 25.370  Millions$ 251.179  Millions
Tetraphase Pharmaceuticals Inc  0.09 $ 7.924  Millions$ 84.742  Millions
Dara Biosciences, Inc.  0.09 $ 1.351  Millions$ 14.574  Millions
Processa Pharmaceuticals Inc   0.09 $ 0.256  Millions$ 2.824  Millions
Sellas Life Sciences Group Inc   0.09 $ 7.560  Millions$ 85.009  Millions
Skinvisible Inc   0.09 $ 0.060  Millions$ 0.682  Millions
Nanomix Corp  0.09 $ 0.267  Millions$ 3.069  Millions
Lineage Cell Therapeutics Inc   0.08 $ 5.035  Millions$ 59.330  Millions
Rennova Health Inc   0.08 $ 0.377  Millions$ 4.474  Millions
Oragenics Inc   0.08 $ 1.154  Millions$ 14.403  Millions
Harrow Inc   0.08 $ 1.113  Millions$ 14.125  Millions
Ptc Therapeutics inc   0.08 $ 16.999  Millions$ 216.524  Millions
Biocorrx Inc   0.08 $ 0.353  Millions$ 4.509  Millions
Regulus Therapeutics Inc   0.08 $ 8.904  Millions$ 116.277  Millions
Cerevel Therapeutics Holdings Inc   0.08 $ 2.404  Millions$ 31.508  Millions
Inovio Pharmaceuticals Inc   0.08 $ 9.739  Millions$ 129.157  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.